Document is current
Any future updates will be listed below
-
Authors
Røndbjerg, Anne Kristine
Gyldenløve, Mette
Krustrup, Dorrit
Rix, Marianne
Vejborg, Ilse
Lonn, Lars
Jørgensen, Niklas Rye
Pasch, Andreas
Skov, Lone
Hansen, Ditte https://orcid.org/0000-0003-4929-7901
-
Funding
Funding for this research was provided by:
Dansk Nefrologisk Selskab
Nyreforeningen
Helen og Ejnar Bjørnows Fond
Royal Library, Copenhagen University Library
- License Information
-
More Information
Article History
Received: 12 March 2023
Accepted: 9 June 2023
First Online: 19 July 2023
Declarations
:
: A Pasch is an employee and stockholder of Calciscon AG, Biel, Switzerland, which commercializes the T50 test. DH, MD, DK, MR, IV, LL, NJ, LS, DH have no competing interests.
: The study was conducted according to the latest revision of the Helsinki Declaration. The protocol was approved by the research ethics committee of the Capital Region of Denmark (H-15003900) and the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: Written informed consent was obtained from all participants before screening.
